title: Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats.
abstract: Ischemic acute renal failure (iARF) was described to reduce renal extraction of the organic anion para-aminohippurate (PAH) in humans. The rate-limiting step of renal organic anion secretion is its basolateral uptake into proximal tubular cells. This process is mediated by the organic anion transporters OAT1 and OAT3, which both have a broad spectrum of substrates including a variety of pharmaceutics and toxins. Using a rat model of iARF, we investigated whether impairing the secretion of the organic anion PAH might be associated with downregulation of OAT1 or OAT3. Inulin and PAH clearance was determined starting from 6 up to 336 h after ischemia-reperfusion (I/R) injury. Net secretion of PAH was calculated and OAT1 as well as OAT3 expression was analyzed by RT-PCR and Western blotting. Inulin and PAH clearance along with PAH net secretion were initially diminished after I/R injury with a gradual recovery during follow-up. This initial impairment after iARF was accompanied by decreased mRNA and protein levels of OAT1 and OAT3 in clamped animals compared with sham-operated controls. In correlation to the improvement of kidney function, both mRNA and protein levels of OAT1 and OAT3 were upregulated during the follow-up. Thus decreased expression of OAT1 and OAT3 is sufficient to explain the decline of PAH secretion after iARF. As a result, this may have substantial impact on excretion kinetics and half-life of organic anions. As a consequence, the biological effects of a variety of organic anions may be affected after iARF.
authors.affiliation: Institute of Physiology, Division of Nephrology, University of Wuerzburg, Wuerzburg, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Schneider
authors.forename: C
authors.initials: C
authors.lastname: Sauvant
authors.forename: B
authors.initials: B
authors.lastname: Betz
authors.forename: M
authors.initials: M
authors.lastname: Otremba
authors.forename: D
authors.initials: D
authors.lastname: Fischer
authors.forename: H
authors.initials: H
authors.lastname: Holzinger
authors.forename: C
authors.initials: C
authors.lastname: Wanner
authors.forename: J
authors.initials: J
authors.lastname: Galle
authors.forename: M
authors.initials: M
authors.lastname: Gekle
mesh_terms: D000818:Animals; D015153:Blotting, Western; D015536:Down-Regulation; D005260:Female; D007444:Inulin / Q000378:metabolism; D007511:Ischemia / Q000150:complications*; D007668:Kidney / Q000098:blood supply*; D027362:Organic Anion Transport Protein 1 / Q000235:genetics / Q000378:metabolism*; D029362:Organic Anion Transporters, Sodium-Independent / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D051437:Renal Insufficiency / Q000209:etiology / Q000378:metabolism*; D015427:Reperfusion Injury / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D010130:p-Aminohippuric Acid / Q000378:metabolism*
chemical_list: D027362:Organic Anion Transport Protein 1; D029362:Organic Anion Transporters, Sodium-Independent; D012333:RNA, Messenger; C421043:Slc22a6 protein, rat; C114338:organic anion transport protein 3; D007444:Inulin; D010130:p-Aminohippuric Acid